Plant-Based
How Cultivated Meat Startup SCiFi Foods Used #CRISPR to Achieve Price Parity With Beef
4 Mins Read Bay-Area food-tech startup SCiFi Foods has emerged from stealth mode with a game-changing announcement for the cultivated meat sector. The…

Bay-Area #food-#tech startup SCiFi Foods has emerged from stealth mode with a game-changing announcement for the cultivated meat sector. The company says it has achieved price parity with beef using a proprietary tech combination involving its own high-throughput cell line engineering and CRISPR technology.
“We’ve known from day one that by opting to work on cultivated beef, we were choosing a much bigger challenge in terms of the science and technology required,” SCiFi Foods CEO and co-founder Joshua March said in a statement. “However, beef is the ultimate prize—with both the biggest market demand and the biggest climate impact. This breakthrough illustrates the power of our bioengineering strategy, and is a huge testament to our team and the platform they’ve built.”Price parity
According to SCiFi, its first R&D announcement is also a world’s first achievement—the company, which has raised more than $29 million to date, is the first to produce edible cultivated beef cell lines that grow in a single-cell suspension. “This not only validates SCiFi Foods’ cell line engineering strategy and platform, but also allows the company to reduce the cost of growing its beef cells at scale by at least one thousand times—the biggest zero to one in cultivated meat,” the company said.
CRISPR
Part of the development comes by way of the controversial CRISPR technology. That tech, developed by American biochemist Jennifer Anne Doudna, a Fellow of the Royal Society, was adapted from a genome editing system that bacteria use for immunity. By capturing and inserting small pieces of DNA from the attacking virus into their own DNA, bacteria create what’s called CRISPR arrays. The technology has been eyed as a potential embryonic treatment for a number of hereditary diseases including hemophilia, cystic fibrosis, Alzheimer’s, and Parkinson’s, among others. But for all of its potential, the tech has also brought controversy as studies have found that altering the DNA of embryos or eggs and sperm could cause mutations that create other health threats. The risks don’t just impact the embryo at hand, either; genetic changes would alter the health and health risks of future generations, too, research has found.

Continue Reading